Works matching IS 19466234 AND DT 2020 AND VI 12 AND IP 531

Results: 3
    1

    BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

    Published in:
    Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
    By:
    • Coussy, Florence;
    • El-Botty, Rania;
    • Château-Joubert, Sophie;
    • Dahmani, Ahmed;
    • Montaudon, Elodie;
    • Leboucher, Sophie;
    • Morisset, Ludivine;
    • Painsec, Pierre;
    • Sourd, Laura;
    • Huguet, Léa;
    • Nemati, Fariba;
    • Servely, Jean-Luc;
    • Larcher, Thibaut;
    • Vacher, Sophie;
    • Briaux, Adrien;
    • Reyes, Cécile;
    • La Rosa, Philippe;
    • Lucotte, Georges;
    • Popova, Tatiana;
    • Foidart, Pierre
    Publication type:
    Article
    2
    3

    Long noncoding RNA SNHG12 integrates a DNA-PK--mediated DNA damage response and vascular senescence.

    Published in:
    Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aaw1868
    By:
    • Haemmig, Stefan;
    • Dafeng Yang;
    • Sun, Xinghui;
    • Das, Debapria;
    • Ghaffari, Siavash;
    • Molinaro, Roberto;
    • Lei Chen;
    • Yihuan Deng;
    • Freeman, Dan;
    • Moullan, Norman;
    • Tesmenitsky, Yevgenia;
    • Wara, A. K. M. Khyrul;
    • Simion, Viorel;
    • Shvartz, Eugenia;
    • Lee, James F.;
    • Tianlun Yang;
    • Sukova, Galina;
    • Marto, Jarrod A.;
    • Stone, Peter H.;
    • Lee, Warren L.
    Publication type:
    Article